The economic cost of infertility-related services: an examination of the Massachusetts infertility insurance mandate

Fertility and Sterility
M Griffin, W F Panak

Abstract

To examine the costs and outcomes of infertility-related services in Massachusetts during a time of expanded use of assisted reproductive technology (ART). Cost data were obtained from the Massachusetts Department of Insurance Rate-Setting Commission and 9 large group insurance plans for the period 1986-1993. Utilization and success rates of ART were examined, and the cost per live delivery with the use of ART in 1993 was estimated. The state of Massachusetts, in which access to infertility-related services has been mandated by law since 1989. The study population consisted of 8 large health maintenance organization plans and the Blue Cross/Blue Shield indemnity plan. None. Per capita infertility-related expenditures, infertility-related expenditures as a percentage of total expenditures, live deliveries per initiated ART cycle, and cost per live delivery. Expenditures for infertility services increased at a rate similar to or slower than inflation during the years 1988-1992. Increases were slowest in health maintenance organizations, probably as a result of provider arrangements. Infertility services accounted for 0.41% of total expenditures within the indemnity plan in 1993 (approximately $1.71 per contract-month). Examinatio...Continue Reading

References

Aug 1, 1986·American Journal of Public Health·G S Cooper
Jul 28, 1994·The New England Journal of Medicine·P J NeumannM C Weinstein
Dec 2, 1993·The New England Journal of Medicine·H W Jones, J P Toner
May 1, 1997·Fertility and Sterility·B J Van VoorhisF K Chapler
Jul 1, 1993·The Journal of Social Issues·M S Henifin

❮ Previous
Next ❯

Citations

Oct 27, 2006·Maternal and Child Health Journal·Blair Johnson, Wendy Chavkin
Jul 10, 2003·Fertility and Sterility·David Frankfurter
May 10, 2000·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·C SuchartwatnachaiA Rojanasakul
Jun 10, 2010·Human Reproduction Update·Mark P ConnollyUNKNOWN ESHRE Reproduction and Society Task Force
Feb 12, 2000·Public Health Reports·A T Fidler, J Bernstein
Aug 3, 2013·Fertility and Sterility·Georgina M ChambersMarinus J C Eijkemans
Nov 10, 2012·Fertility and Sterility·Kenan Omurtag, G David Adamson
Dec 23, 2008·Fertility and Sterility·Anjani Chandra, Elizabeth Hervey Stephen
Nov 11, 2008·Fertility and Sterility·Maurizio MacalusoLori A Pollack
Mar 28, 2008·Fertility and Sterility·Joseph C Isaacs
Nov 30, 2006·Journal of Health Economics·Lucie Schmidt
Dec 22, 2004·Sociology of Health & Illness·Daphna Birenbaum-Carmeli
Sep 11, 2003·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Carson Strong
Jun 14, 2012·Health Economics·Kasey S Buckles
Jun 23, 2000·Clinics in Perinatology·J A ZupancicM C McCormick
Apr 8, 2016·Fertility and Sterility·Akanksha MehtaJames F Smith
Jun 23, 2007·Human Reproduction·Guido Pennings, Willem Ombelet
Jan 3, 2019·Maternal and Child Health Journal·Sheree L BouletScott D Grosse
Nov 26, 2010·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Daniel BascoSarah Rodriguez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.